Pfizer and scientists at the University College London's Institute of Ophthalmology have asked U.K. regulators to allow them to start a clinical trial of retinal cells, derived from human embryonic stem cells, in patients with age-related macular degeneration. They hope to conduct the U.K. study in 2012.
Pfizer, U.K. experts seek approval for stem cell clinical trial
SmartBrief Job Listings for Health Care
|Senior Research Analyst||
America's Health Insurance Plans (AHIP)
|Manager, Regulatory Affairs||
|Washington DC, DC|
|Senior Counsel - FDA Regulatory Affairs||
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|